PF 5901
Alternative Names: L 655238; REV 5901; Revlon 5901; RG 5901; RG 5901ALatest Information Update: 09 Jan 2003
Price :
$50 *
At a glance
- Originator Purdue Frederick
- Class Antiasthmatics; Quinolines; Small molecules
- Mechanism of Action 5-lipoxygenase inhibitors; Leukotriene B4 receptor antagonists; Leukotriene C4 receptor antagonists; Leukotriene D4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Ocular inflammation
Most Recent Events
- 09 Jan 2003 Discontinued - Clinical-Phase-Unknown for Asthma in USA (PO)
- 09 Jan 2003 Discontinued - Preclinical for Ocular inflammation in USA (Ophthalmic)
- 08 Jul 2002 No development reported - Clinical-Phase-Unknown for Asthma in USA (PO)